Fed. Circ. Keeps Ban On Roche's US Mircera Sales
A federal appeals court refused again Tuesday to overturn an injunction barring Hoffmann-La Roche Inc. from selling its anemia drug Mircera in the U.S., but did partially reinvigorate the Swiss drugmaker's...To view the full article, register now.
Already a subscriber? Click here to view full article